Steven Cohen's position in Adaptive Biotechnologies is currently worth $10.7 Million. That's 0.03% of their equity portfolio (526th largest holding). The investor owns 2.22% of the outstanding Adaptive Biotechnologies stock. The first Adaptive Biotechnologies trade was made in Q2 2019. Since then Steven Cohen bought shares one more times and sold shares on two occasions. The investor's estimated purchase price is $24.6 Million, resulting in a loss of 56%.
Related Stocks: ADPT ,
GuruFocus, over 2 years agoRelated Stocks: ADPT ,
GuruFocus, over 2 years agoRelated Stocks: ADPT ,
GuruFocus, over 2 years agoRelated Stocks: ADPT ,
GuruFocus, almost 3 years ago